1. Home
  2. UTF vs RDY Comparison

UTF vs RDY Comparison

Compare UTF & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTF
  • RDY
  • Stock Information
  • Founded
  • UTF 2004
  • RDY 1984
  • Country
  • UTF United States
  • RDY India
  • Employees
  • UTF N/A
  • RDY N/A
  • Industry
  • UTF Finance Companies
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • UTF Finance
  • RDY Health Care
  • Exchange
  • UTF Nasdaq
  • RDY Nasdaq
  • Market Cap
  • UTF 2.6B
  • RDY 2.1B
  • IPO Year
  • UTF N/A
  • RDY N/A
  • Fundamental
  • Price
  • UTF $26.80
  • RDY $14.53
  • Analyst Decision
  • UTF
  • RDY Strong Buy
  • Analyst Count
  • UTF 0
  • RDY 2
  • Target Price
  • UTF N/A
  • RDY $16.95
  • AVG Volume (30 Days)
  • UTF 171.7K
  • RDY 1.5M
  • Earning Date
  • UTF 01-01-0001
  • RDY 07-28-2025
  • Dividend Yield
  • UTF 7.19%
  • RDY 0.56%
  • EPS Growth
  • UTF N/A
  • RDY 1.47
  • EPS
  • UTF 2.84
  • RDY 0.79
  • Revenue
  • UTF $138,636,669.00
  • RDY $3,809,801,863.00
  • Revenue This Year
  • UTF N/A
  • RDY $10.24
  • Revenue Next Year
  • UTF N/A
  • RDY N/A
  • P/E Ratio
  • UTF $9.16
  • RDY $18.39
  • Revenue Growth
  • UTF 19.80
  • RDY 16.61
  • 52 Week Low
  • UTF $22.05
  • RDY $12.26
  • 52 Week High
  • UTF $26.53
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • UTF 60.02
  • RDY 37.98
  • Support Level
  • UTF $26.61
  • RDY $14.81
  • Resistance Level
  • UTF $26.87
  • RDY $15.25
  • Average True Range (ATR)
  • UTF 0.25
  • RDY 0.20
  • MACD
  • UTF -0.02
  • RDY -0.12
  • Stochastic Oscillator
  • UTF 63.25
  • RDY 5.18

About UTF Cohen & Steers Infrastructure Fund Inc

Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. It invests majority of its managed assets in securities issued by infrastructure companies, which consists of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies, under normal market conditions.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: